Stay updated with breaking news from Lexeo therapeutic. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Lexeo Therapeutics, Inc. Forecasted to Post FY2027 Earnings of ($2.58) Per Share (NASDAQ:LXEO) themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Entera Bio (NASDAQ:ENTX – Get Free Report) and Lexeo Therapeutics (NASDAQ:LXEO – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, risk, analyst recommendations, profitability, valuation, dividends and institutional ownership. Earnings & Valuation This table compares Entera […] ....
Lexeo Therapeutics’ (NASDAQ:LXEO – Get Free Report) quiet period will expire on Wednesday, December 13th. Lexeo Therapeutics had issued 9,090,910 shares in its public offering on November 3rd. The total size of the offering was $100,000,010 based on an initial share price of $11.00. During Lexeo Therapeutics’ quiet period, insiders and underwriters involved in the […] ....
Chardan Capital initiated coverage on shares of Lexeo Therapeutics (NASDAQ:LXEO – Free Report) in a report issued on Tuesday, MarketBeat reports. The firm issued a buy rating and a $23.00 price objective on the stock. Chardan Capital also issued estimates for Lexeo Therapeutics’ FY2023 earnings at ($3.30) EPS and FY2024 earnings at ($2.74) EPS. Lexeo […] ....